[1]
Muhammad Ridwan, Roza Kurniati, and Fauzar, “Comparative Efficacy, Safety, and Patient Preference of One-Month (1HP) versus Three-Month (3HP) Rifapentine-Based Regimens for Latent Tuberculosis: A Network Meta-Analysis of HIV, Silicosis, and General Risk Populations”, Bioscmed, vol. 10, no. 3, pp. 974-987, Jan. 2026.